Antivirus untuk Influenza
DOI:
https://doi.org/10.55175/cdk.v45i4.799Kata Kunci:
Amantadine, antivirus, influenza, oseltamivir, riamtadine, zanamivirAbstrak
Influenza adalah salah satu penyakit infeksi saluran napas yang paling sering, menyebabkan 3 sampai 5 juta kasus berat dan 250.000 sampai 500.000 kematian setiap tahun (WHO). Vaksinasi influenza dapat mengurangi risiko influenza, sebaiknya dilakukan secara rutin setiap tahun. Pengobatan influenza biasanya simptomatik, suplementasi, dan istirahat. Ada beberapa obat antivirus untuk influenza, seperti: oseltamivir, zanamivir, amantadine, dan rimantadine. Di Indonesia, antivirus untuk influenza relatif kurang dikenal karena distribusinya sepenuhnya dikendalikan oleh Departemen Kesehatan. Tenaga kesehatan seyogyanya lebih mengenal profil farmakodinamik dan farmakokinetik obat-obat antivirus ini.
Influenza is one of the most common respiratory tract infections, with 3 to 5 million severe cases, and 250.000 to 500.000 deaths yearly (WHO). Vaccination could reduce the risk of influenza, it should be done routinely every year. Influenza treatment usually involves symptomatic, supplementation, and rest. Internationally, several antivirus medications for influenza are oseltamivir, zanamivir, amantadine, and rimantadine. In Indonesia, distribution of antiviral for influenza is regulated by Ministry of Health. Health practitioners should get acquainted with the pharmacodynamic and pharmacokinetic of these antiviral medications
Unduhan
Referensi
WHO. Influenza (seasonal) [Internet]. WHO. [cited 2017 Oct 23]. Available from: http://www.who.int/mediacentre/factsheets/fs211/en/
WHO. What is a pandemic? [Internet]. WHO. [cited 2017 Oct 23]. Available from: http://www.who.int/csr/disease/swineflu/frequently_asked_questions/pandemic/en/
Potter CW. A history of influenza. J Appl Microbiol. 2001;91(4):572–9.
WHO. Ten things you need to know about pandemic influenza [Internet]. 2009 [cited 2017 Oct 23]. Available from: http://www.who.int/csr/disease/influenza/pandemic10things/en/index.html
Centers for Disease Control and Prevention. Influenza type A viruses | Avian influenza (flu) [Internet]. 2017 [cited 2017 Oct 23]. Available from: https://www.cdc.gov/flu/avianflu/influenza-a-virus-subtypes.htm
Tong S, Zhu X, Li Y, Shi M, Zhang J, Bourgeois M, et al. New world bats harbor diverse influenza A viruses. PLoS Pathog. 2013;9(10):e1003657.
Klimov AI, Garten R, Russell C, Barr IG, Besselaar TG, Daniels R, et al. WHO recommendations for the viruses to be used in the 2012 Southern Hemisphere influenzavaccine: epidemiology, antigenic and genetic characteristics of influenza A(H1N1)pdm09, A(H3N2) and B influenza viruses collected from February to September2011. Vaccine. 2012;30(45):6461–71.
Centers for Disease Control and Prevention. Types of influenza viruses | Seasonal influenza (flu) | CDC [Internet]. 2017 [cited 2017 Oct 23]. Available from: https://www.cdc.gov/flu/about/viruses/types.htm
Guo YJ, Jin FG, Wang P, Wang M, Zhu JM. Isolation of influenza C virus from pigs and experimental infection of pigs with influenza C virus. J Gen Virol. 1983;64 (Pt1):177–82.
Eccles R. Understanding the symptoms of the common cold and influenza. Lancet Infect Dis. 2005;5(11):718–25.
Suzuki E, Ichihara K, Johnson AM. Natural course of fever during influenza virus infection in children. Clin Pediatr (Phila). 2007;46(1):76–9.
Palmenberg AC, Spiro D, Kuzmickas R, Wang S, Djikeng A, Rathe JA, et al. Sequencing and analyses of all known human rhinovirus genomes reveal structure and evolution. Science. 2009;324(5923):55–9.
Centers for Disease Control and Prevention. Guidance for clinicians on the use of RT-PCR and other molecular assays for diagnosis of influenza virus infection Seasonal influenza (flu) | CDC [Internet]. 2017 [cited 2017 Oct 23]. Available from: https://www.cdc.gov/flu/professionals/diagnosis/molecular-assays.htm
Accuracy of rapid influenza diagnostic tests: A meta-analysis [Internet]. [cited 2017 Oct 23]. Available from: https://reference.medscape.com/medline/abstract/22371850
CDC. Key facts about seasonal flu vaccine [Internet]. 2017 [cited 2017 Oct 23]. Available from: https://www.cdc.gov/flu/protect/keyfacts.htm
Centers for Disease Control and Prevention. Influenza vaccination: A summary for clinicians | Seasonal influenza (flu) | CDC [Internet]. 2017 [cited 2017 Oct 23]. Available from: https://www.cdc.gov/flu/professionals/vaccination/vax-summary.htm
Lansbury LE, Smith S, Beyer W, Karamehic E, Pasic-Juhas E, Sikira H, et al. Effectiveness of 2009 pandemic influenza A(H1N1) vaccines: A systematic review and metaanalysis. Vaccine. 2017;35(16):1996–2006.
Centers for Disease Control and Prevention. Quadrivalent influenza vaccine | Seasonal influenza (flu) | CDC [Internet]. 2017 [cited 2017 Oct 23]. Available from: https://www.cdc.gov/flu/protect/vaccine/quadrivalent.htm
Medscape. Effectiveness of antiviral treatment in human influenza A(H5N1) infections: Analysis of a Global Patient Registry [Internet]. [cited 2017 Oct 23]. Available from: https://reference.medscape.com/medline/abstract/20831384
Stiver G. The treatment of influenza with antiviral drugs. CMAJ Can Med Assoc J. 2003;168(1):49–57.
Drugs.com. Amantadine - FDA prescribing information, side effects and uses [Internet]. [cited 2017 Oct 23]. Available from: https://www.drugs.com/pro/amantadine.html
Jefferson T, Deeks JJ, Demicheli V, Rivetti D, Rudin M. Amantadine and rimantadine for preventing and treating influenza A in adults. Cochrane Database Syst Rev.2004;(3):CD001169.
Lee J, Song YJ, Park JH, Lee JH, Baek YH, Song M-S, et al. Emergence of amantadine-resistant H3N2 Avian influenza A virus in South Korea. J Clin Microbiol. 2008;46(11):3788–90.
Deyde VM, Xu X, Bright RA, Shaw M, Smith CB, Zhang Y, et al. Surveillance of resistance to adamantanes among influenza A(H3N2) and A(H1N1) viruses isolated worldwide. J Infect Dis. 2007;196(2):249–57.
Govorkova EA, Fang HB, Tan M, Webster RG. Neuraminidase inhibitor-rimantadine combinations exert additive and synergistic anti-influenza virus effects in MDCK cells. Antimicrob Agents Chemother. 2004;48(12):4855–63.
CDC. Seasonal Influenza (Flu) - Weekly report: Influenza summary update [Internet]. [cited 2017 Oct 31]. Available from: https://www.cdc.gov/flu/weekly/weeklyarchives2008-2009/weekly35.htm
CDC. Antiviral agents for the treatment and chemoprophylaxis of influenza [Internet]. [cited 2017 Oct 23]. Available from: https://www.cdc.gov/mmwr/preview/mmwrhtml/rr6001a1.htm
Departemen Kesehatan. Pharmaceutical care untuk pasien flu burung. 2007.
Storms AD, Gubareva LV, Su S, Wheeling JT, Okomo-Adhiambo M, Pan CY, et al. Oseltamivir-resistant pandemic (H1N1) 2009 virus infections, United States, 2010-11. Emerg Infect Dis. 2012;18(2):308–11.
Nitsch-Osuch A, Brydak LB. Influenza viruses resistant to neuraminidase inhibitors. Acta Biochim Pol. 2014;61(3):505–8.
Menteri Kesehatan Republik Indonesia. Pedoman penanggulangan episenter pandemi influenza, Kepetusan Menteri Kesehatan RI No 300/MENKES/SK/IV/2009.
Unduhan
Diterbitkan
Cara Mengutip
Terbitan
Bagian
Lisensi
Hak Cipta (c) 2018 https://creativecommons.org/licenses/by-nc/4.0/
Artikel ini berlisensi Creative Commons Attribution-NonCommercial 4.0 International License.
